Lymph node micrometastases of cutaneous melanoma: Increased sensitivity of molecular diagnosis in comparison to immunohistochemistry

International Journal of Cancer

Volumn 79, Issue 4, 1998, Pages 318-323

  Blaheta, Hans Juergen ^a   Schittek, Birgit ^a   Breuninger, Helmut ^a   Maczey, Evelyn ^a   Kroeber, Stefan ^a   Sotlar, Karl ^a   Ellwanger, Ulf ^a   Themen, Marcel H ^a   Rassner, Gernot ^a   Bültmann, Burkhard ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; OCCULT CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CANCER;

HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; MONOPHENOL MONOOXYGENASE; POLYMERASE CHAIN REACTION; PROGNOSIS; RESTRICTION MAPPING; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031827792     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980821)79:4<318::AID-IJC3>3.0.CO;2-Y     Document Type: Article

References (22)

1. BATTAYANI, Z., GROB, J.J., XERRI, L., NOE, C., ZAROUR, H., HOUVAE-NEGHEL, G., DELPERO, J.R., BIRMBAUM, D., HASSOUN, J. and BONERANDI, J.J., Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch. Dermatol., 131, 443-447 (1995).
2. BAUTISTA, N.C., COHEN, S. and ANDERS, K.H., Benign melanocytic nevus cells in axillary lymph nodes. Amer. J. clin. Pathol., 102, 102-108 (1994).
3. BELL, M.E.A., HILL, D.P. and BARGHAVA, M.K., Lymphatic invasion in pigmented nevi. Amer. J. clin. Pathol., 72, 97-100 (1979).
4. BRESLOW, A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg., 172, 902-908 (1970).
5. BÜTTNER, P. and 13 OTHERS, Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer, 75, 2499-2506 (1995).
6. CARSON, K.F., WEN, D.-R., LI, P.-X., LANA, A.M., BAILLY, C., MORTON, D.L. and COCHRAN, A.J., Nodal nevi and cutaneous melanomas. Amer. J. surg. Pathol., 20, 834-840 (1996).
7. COCHRAN, A.J., WEN, D.R. and MORTON D.L., Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. Amer. J. surg. Pathol., 12, 612-618 (1988).
8. DREPPER, H. and 13 OTHERS, Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer, 72, 741-749 (1993).
9. ERCOLANI, L., FLORENCE, B., DENARO, M. and ALEXANDER, M., Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. biol. Chem., 263, 15335-15341 (1988).
10. HSU, S.M., RAINE, L. and FANGER, H., Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580 (1981).
11. KUNTER, U., BUER, J., PROBST, M., DUENSING, S., DALLMANN, I., GROSSE, J., KIRCHNER, H., SCHLUEPEN, E.M., VOLKENANDT, M., GANSER, A. and ATZPODIEN, J., Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma [see comments]. J. nat. Cancer Inst., 88, 590-594 (1996).
12. KWON, B.S., HAQ, A.K., POMERANTZ, S.H. and HALABAN, R., Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus [published erratum appears in Proc. nat. Acad. Sci. (Wash.) 1988 Sep;85(17):6352]. Proc. nat. Acad. Sci. (Wash.), 84, 7473-7477 (1987).
13. LITTLE, J.H., DAVIS, N.C., Secondary malignant melanoma in lymph nodes: incidence, time of occurrence, and mortality. Austr. N. Z. J. Surg., 48, 9-13 (1978).
14. MELLADO, B., COLOMER, D., CASTEL, T., MUÑOZ, M., CARBALLO, E., GALAN, M., MASCARO, J.M., VIVES CORRONS, J.L., GRAU, J.J. and ESTAPE, J., Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J. clin. Oncol., 14, 2091-2097 (1996).
15. MORTON, D.L., WANEK, L., NIZZE, J.A., ELASHOFF, R.M. and WONG, J.H., Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann. Surg., 214, 491-499 (1991).
16. MORTON, D.L., WEN, D.R., WONG, J.H., ECONOMOU, J.S., CAGLE, L.A., STORM, F.K., FOSHAG, L.J. and COCHRAN, A.J., Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg., 127, 392-399 (1992).
17. REINTGEN, D. and 13 OTHERS, The orderly progression of melanoma nodal metastases. Ann. Surg., 220, 759-767 (1994).
18. RIDOLFI, R.L., ROSEN, P.P. and THALER, H., Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance. Cancer, 39, 164-171 (1977).
19. SCHWÜRZER-VOIT, M., PROEBSTLE, T.M. and STERRY, W., Identification of lymph node metastases by use of polymerase chain reaction (PCR) in melanoma patients. Europ. J. Cancer, 32A, 264-268 (1996).
20. SMITH, B., SELBY, P., SOUTHGATE, J., PITTMAN, K., BRADLEY, C. and BLAIR, G.E., Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338, 1227-1229 (1991).
21. VAN DER VELDE ZIMMERMANN, D., ROIJERS, J.F., BOUWENS-ROMBOUTS, A., DE WEGER, R.A., DE GRAAF, P.W., TILANUS, M.G. and VAN DEN TWEEL, J.G., Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Amer. J. Pathol., 149, 759-764 (1996).
22. WANG, X. and 14 OTHERS, Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann. Surg., 220, 768-774 (1994).